The behavioral effects of NMDA antagonists in serotonin depleted rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 159-166

  PLaznik A ^a,b   Jessa, M ^a   Nazar, M ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

5.7 DHT; CGP 37849; Dopamine turnover; Exploration; Locomotor activity; MK 801; Rats; Vogel's test

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 5,7 DIHYDROXYTRYPTAMINE; DIZOCILPINE; DOPAMINE; HOMOVANILLIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORADRENALIN; SEROTONIN;

ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN INJURY; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; DOPAMINE METABOLISM; DOSE RESPONSE; EXPLORATORY BEHAVIOR; FOREBRAIN; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

2-AMINO-5-PHOSPHONOVALERATE; 5,7-DIHYDROXYTRYPTAMINE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CONFLICT (PSYCHOLOGY); DIZOCILPINE MALEATE; DRINKING BEHAVIOR; EXCITATORY AMINO ACID ANTAGONISTS; MALE; PAIN THRESHOLD; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN; SEROTONIN AGENTS;

ANIMALIA;

EID: 0343051795     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00375-9     Document Type: Article

References (36)

1. 3H]aspartate labelling of possible excitatory amino acid inputs Neuroscience. 37:1990;77-100.
2. Becquet D., Hery M., Deprez P., Faudon M., Fache M. P., Giraud P., Hery F. N-methyl-D-aspartic acid/glycine interactions on the control of 5-hydroxytryptamine release in raphe primary cultures. J. Neurochem. 61:1993;1692-1697.
3. Briley M., Chopin Ph., Moret Ch. Effect of serotonergic lesion on " anxious" behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology. 101:1990;187-189.
4. Brudzynski S. M., Mogenson G. J. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine in the nucleus accumbens. Brain Res. 334:1985;77-84.
5. Erinoff L., Snodgrass S. R. Effects of adult and neonatal treatment with 6-hydroxydopamine or 5,7-Dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine. Pharmacol. Biochem. Behav. 24:1986;1039-1045.
6. Gately P. F., Poon S. L., Segal D. S., Geyer M. A. Depletion of brain serotonin by 5,7-dihydroxytryptamine alters the responses to amphetamine and the habituation of locomotor activity in rats. Psychopharmacology. 87:1985;400-405.
7. Glowinski J. L., Iversen L. L. Regional studies of catecholamines in the rat brain. J. Neurochem. 13:1966;655-669.
8. Hicks T. P., Krupa M., Crepel F. Selective effects of serotonin upon excitatory amino acid-induced depolarizations of Purkinje cells in cerebellar slices from young rats. Brain Res. 492:1989;371-376.
9. Hiramatsu M., Cho A. K., Nabeshima T. Comparison of the behavioural and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur. J. Pharmacol. 166:1989;359-366.
10. Hiramatsu M., Yokoyama S., Nabeshima T., Kameyama T. Changes in concentrations of dopamine, serotonin and their metabolites induced by carbon monoxide (CO) in the rat striatum as determined by in vivo microdialysis. Pharmacol. Biochem. Behav. 48:1994;9-15.
11. Iversen S. D. Interactions between excitatory amino acids and dopamine systems in the forebrain. implications for schizophrenia and Parkinson's disease Behavioural Pharmacology. 6:1995;478-491.
12. 1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum. J. Pharmacol. Exp. Therap. 266:1993;133-141.
13. 3H]aspartate tracing. Brain Res. 360:1985;285-297.
14. 1A agonists into the median raphe nucleus. Soc. Neurosci. Abstr. 19:1993;43.
15. Kinney G. G., Kocsis B., Vertes R. P. Injections of excitatory amino acid antagonists into the median raphe nucleus produced hippocampal theta rhythm in the urethane-anesthetized rats. Brain Res. 654:1994;96-104.
16. Leung L. W. S., Desborough K. A. APV, and N-methyl-D-aspartate receptor agonist, blocks the hippocampal theta rhythm in behaving rats. Brain Res. 463:1988;148-152.
17. Lipska B. K., Jaskiw G. E., Arya A., Weinberger D. R. Serotonin depletion causes long-term reduction of exploration in the rat. Pharmacol. Biochem. Behav. 43:1992;1247-1252.
18. Löscher W., Honack D. The behavioural effects of MK-801 in rats. involvement of dopaminergic, serotonergic and noradrenergic systems Eur. J. Pharmacol. 215:1992;199-208.
19. Löscher W., Annies R., Honack D. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. Eur. J. Pharmacol. 242:1993;263-274.
20. Lyness W. H., Moore K. E. Destruction of 5-hydroxytryptaminergic neurons and the dynamics of dopamine in nucleus accumbens septi and other forebrain regions of the rat. Neuropharmacology. 20:1981;327-334.
21. MacCall R. B., Aghajanian G. K. Serotonergic facilitation of facial motoneuron excitation. Brain Res. 169:1979;11-27.
22. Marona-Lewicka D., Nichols D. E. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan. Eur. J. Pharmacol. 258:1994;1-13.
23. 3H]-glutamate binding by serotonin in the rat hippocampus. an autoradiographic study Life Sci. 49:1991;283-292.
24. 2 receptor subtypes in modulating behaviour induced by excitatory amino acid receptor agonists in mice. Brain Res. 626:1993;78-82.
25. Nedergaard S., Engberg I., Flatman J. A. Serotonin facilitates NMDA responses of cat neocortical neurons. Acta Physiol. Scand. 128:1986;323-325.
26. Ohta K., Araki N., Shibata M., Komatsumoto S., Shimazu K., Fukuuchi Y. Presynaptic ionotropic glutamate receptors modulate in vivo release and metabolism of striatal dopamine, noradrenaline, and 5-hydroxytryptamine. involvement of both NMDA and AMPA/kainate subtypes Neurosci. Res. 21:1994;83-89.
27. Okuyama S., Imagawa Y., Sakagawa T., Nakazato A., Yamagichi K., Katoh M., Yamada S., Araki H., Otomo S. NE-100, a novel sigma receptor ligand. effect on phencyclidine-induced behaviors in rats, dogs and monkeys Life Sci. 55:1994;PL133-138.
28. Pellegrino, L. J.; Pellegrino, A. S.; Cushman, A.J.: A Stereotaxic Atlas of the Rat Brain. New York: Plenum Press, 1967.
29. Plaznik A., Kostowski W, Stefanski R. Limbic mechanisms of anxiolytics acting on 5-HT receptors. Pol. J. Pharmacol. 46:1994;473-477.
30. Plaznik A., Palejko W., Nazar M., Jessa M. Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur. J. Neuropsychopharmacol. 4:1994;503-512.
31. Reader T. A., Gauthier P. Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5,7-DHT and p-CPA. J. Neural Transm. 59:1984;207-227.
32. Söderpalm B., Engel J. A. The 5,7-DHT-induced anticonflict effect is dependent on intact adrenocortical function. Life Sci. 51:1992;315-326.
33. 1A receptor agonists. Neuropharmacology. 32:1993;977-985.
34. Tanyiama K., Nitsch C., Wagner A., Hassler R. Aspartate, glutamate, and GABA levels in pallidum, substantia nigra, center median and dorsal raphe nuclei after cylindric lesion of caudate nucleus in cat. Neurosci. Lett. 16:1980;155-160.
35. Wedzony K., Golembiowska K., Zazula M. Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. N. S. Arch. Pharmacol. 350:1994;555-562.
36. Wirtshafter D., Trifunovic R., Krebs J. C. Behavioral and biochemical evidence for a functional role of excitatory amino acids in the median raphe nucleus. Brain Res. 482:1989;225-234.